Telephone
N/A
Address
Suite 2, Level 37 360 Elizabeth Street Melbourne, Victoria (VIC) 3000
Description
Althea Group Holdings Ltd. is an investment company. Through its subsidiary Althea Company Pty Ltd, it holds number of licenses and permits for the importation, cultivation, production, and supply of medicinal cannabis. It operates through the following geographical segments: Australia, United Kingdom, and Canada. The company was founded by Joshua Fegan on June 21, 2018 and is headquartered in Melbourne, Australia.
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.03 - 0.07
Trade Value (12mth)
AU$6,718.00
1 week
2.63%
1 month
-9.3%
YTD
-38.1%
1 year
-40.91%
All time high
1.445
EPS 3 yr Growth
-39.100%
EBITDA Margin
-39.40%
Operating Cashflow
-$6m
Free Cash Flow Return
-16.30%
ROIC
-35.60%
Interest Coverage
-12.10
Quick Ratio
0.60
Shares on Issue (Fully Dilluted)
381m
HALO Sector
Healthcare
Next Company Report Date
29-Aug-24
Ex Dividend Date (est.)
N/A
Next Dividend Pay Date (est.)
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.00
Date | Announcements |
---|---|
31 October 22 |
Trading Halt
×
Trading Halt |
31 October 22 |
Monthly Activities/Appendix 4C Cash Flow Report
×
Monthly Activities/Appendix 4C Cash Flow Report |
31 January 23 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
31 August 23 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
31 August 23 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
31 August 22 |
Appendix 4G and Corporate Governance Statement
×
Appendix 4G and Corporate Governance Statement |
31 August 22 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
31 August 21 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
30 October 19 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 October 18 |
Notice of Annual General Meeting/Proxy Form
×
Notice of Annual General Meeting/Proxy Form |
30 November 22 |
Results of Meeting
×
Results of Meeting |
30 November 22 |
Share Purchase Plan - Closing Date Extended
×
Share Purchase Plan - Closing Date Extended |
30 January 23 |
AGH Secures New CAD$2 Million Loan Facility
×
AGH Secures New CAD$2 Million Loan Facility |
29 November 22 |
CEO Address To Shareholders
×
CEO Address To Shareholders |
29 January 20 |
Investor Presentation
×
Investor Presentation |
27 July 23 |
Cleansing Notice
×
Cleansing Notice |
27 July 21 |
Investor Presentation
×
Investor Presentation |
27 January 22 |
Application for quotation of securities - AGH
×
Application for quotation of securities - AGH |
27 January 22 |
Notification regarding unquoted securities - AGH
×
Notification regarding unquoted securities - AGH |
27 January 22 |
Application for quotation of securities - AGH
×
Application for quotation of securities - AGH |
27 January 22 |
Issuing of Securities and Options
×
Issuing of Securities and Options |
27 January 22 |
Change in substantial holding
×
Change in substantial holding |
27 February 23 |
Half Yearly Report and Accounts
×
Half Yearly Report and Accounts |
27 August 20 |
Annual Report to Shareholders
×
Annual Report to Shareholders |
26 October 23 |
Althea THC20CBD1 Approved For Reimbursement In Ireland
×
Althea THC20CBD1 Approved For Reimbursement In Ireland |
26 July 23 |
Application for quotation of securities - AGH
×
Application for quotation of securities - AGH |
26 April 22 |
Quarterly Activities/Appendix 4C Cash Flow Report
×
Quarterly Activities/Appendix 4C Cash Flow Report |
24 May 22 |
Change in substantial holding
×
Change in substantial holding |
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Historical data
Forecasted data
Load More
Load Less
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Month Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
Unlock true investor intelligence
Research, trade and manage global markets from one place with HALO Global. It’s trading - the way you want it.
Get the latest insights and hot tips delivered right to your inbox
HALO Technologies Pty Ltd ABN 54 623 830 866 is a Corporate Authorised Representative No 1261916 of Macrovue Pty Ltd ABN 98 600 022 679 AFSL 484264. Macrovue Pty Ltd is a wholly owned subsidiary of HALO Technologies Pty Ltd.